[go: up one dir, main page]

AU5213199A - Human aspartic proteases - Google Patents

Human aspartic proteases

Info

Publication number
AU5213199A
AU5213199A AU52131/99A AU5213199A AU5213199A AU 5213199 A AU5213199 A AU 5213199A AU 52131/99 A AU52131/99 A AU 52131/99A AU 5213199 A AU5213199 A AU 5213199A AU 5213199 A AU5213199 A AU 5213199A
Authority
AU
Australia
Prior art keywords
aspartic proteases
human aspartic
human
proteases
aspartic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52131/99A
Inventor
Olga Bandman
Sandra A. Bruno
Victoria L. Cohan
Laura A. Elsenboss
Michael Fogliano
Hong Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Publication of AU5213199A publication Critical patent/AU5213199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478Aspartic endopeptidases (3.4.23)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
AU52131/99A 1998-07-16 1999-07-15 Human aspartic proteases Abandoned AU5213199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11664198A 1998-07-16 1998-07-16
US09116641 1998-07-16
PCT/US1999/015988 WO2000004137A1 (en) 1998-07-16 1999-07-15 Human aspartic proteases

Publications (1)

Publication Number Publication Date
AU5213199A true AU5213199A (en) 2000-02-07

Family

ID=22368386

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52131/99A Abandoned AU5213199A (en) 1998-07-16 1999-07-15 Human aspartic proteases

Country Status (5)

Country Link
EP (1) EP1030911A1 (en)
JP (1) JP2002520048A (en)
AU (1) AU5213199A (en)
CA (1) CA2303062A1 (en)
WO (1) WO2000004137A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0897986A3 (en) * 1997-08-21 2000-07-05 Smithkline Beecham Corporation Aspartic proteinase 5 (ASP5)
US7045333B1 (en) 1998-01-16 2006-05-16 Incyte Corporation Human protease molecules
US7160679B1 (en) 1998-05-21 2007-01-09 Diadexus, Inc. Method of diagnosing, monitoring, and staging lung cancer
WO2002000891A2 (en) * 2000-06-26 2002-01-03 Bayer Aktiengesellschaft Human napsin-like aspartyl protease
EP1500663A1 (en) * 2000-09-28 2005-01-26 Eli Lilly And Company Secreted proteins and their uses
AU2003268023A1 (en) * 2002-07-23 2004-02-09 Incyte Corporation Protein modification and maintenance molecules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618966D0 (en) * 1996-09-11 1996-10-23 Smithkline Beecham Plc Novel compounds
PT948630E (en) * 1996-11-20 2008-06-11 Oklahoma Med Res Found Cloning and characterization of napsin, an aspartic protease

Also Published As

Publication number Publication date
EP1030911A1 (en) 2000-08-30
WO2000004137A9 (en) 2000-06-08
JP2002520048A (en) 2002-07-09
CA2303062A1 (en) 2000-01-27
WO2000004137A1 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
AU2113599A (en) Human protease molecules
AU6820000A (en) Novel proteases and variants thereof
AU4214597A (en) Self-secreting proteases
AU2434199A (en) Protein
AU2623899A (en) Novel thiobenzamides
AU5340399A (en) Proteases and associated proteins
AU2653599A (en) Human cystatin f
AU2002224553A1 (en) Human proteases
AU2350199A (en) Novel aminoorganofunctionalsiloxanes
AU4037699A (en) Novel aryl-hydro naphthalenal kanamines
AU3768199A (en) Human protease associated proteins
AU1914400A (en) Human hydrolase proteins
AU2501200A (en) Human peptidases
AU5213199A (en) Human aspartic proteases
AU4992099A (en) Human presenilin-associated protein
AU2285701A (en) Proteases
AU2724799A (en) Novel endo-xylogalacturonase
AU2227999A (en) Human ependymin
GB9821198D0 (en) Enzyme
AU2593199A (en) Human smn-like protein
AU1624501A (en) Human serine protease
AU1055399A (en) Rollerboard
AU2202100A (en) Human brainiac-5
AU6522199A (en) Secreted protein zsig49
AU2072699A (en) Mini condom

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase